stella
beta
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma — Stella
Recruiting
Back to HNSCC trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Department of Radiation Oncology, Chengdu, Sichuan
View full record on ClinicalTrials.gov